JP2015516001A5 - - Google Patents

Download PDF

Info

Publication number
JP2015516001A5
JP2015516001A5 JP2015510758A JP2015510758A JP2015516001A5 JP 2015516001 A5 JP2015516001 A5 JP 2015516001A5 JP 2015510758 A JP2015510758 A JP 2015510758A JP 2015510758 A JP2015510758 A JP 2015510758A JP 2015516001 A5 JP2015516001 A5 JP 2015516001A5
Authority
JP
Japan
Prior art keywords
alkyl
group
substituted
cycloalkyl
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015510758A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015516001A (ja
JP6136032B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/059346 external-priority patent/WO2013167514A1/en
Publication of JP2015516001A publication Critical patent/JP2015516001A/ja
Publication of JP2015516001A5 publication Critical patent/JP2015516001A5/ja
Application granted granted Critical
Publication of JP6136032B2 publication Critical patent/JP6136032B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015510758A 2012-05-07 2013-05-06 新規な2,3−ジヒドロ−フロ[2,3−c]ピリジン、Gタンパク質共役受容体GPR119のモジュレーターとしてのそれらの使用、及びそれらを含む医薬組成物 Active JP6136032B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12166992.3 2012-05-07
EP12166992 2012-05-07
PCT/EP2013/059346 WO2013167514A1 (en) 2012-05-07 2013-05-06 New 2,3-dihydro-furo[2,3-c]pyridines, their use as modulators of the g-protein-coupled receptor gpr119 and pharmaceutical compositions comprising them

Publications (3)

Publication Number Publication Date
JP2015516001A JP2015516001A (ja) 2015-06-04
JP2015516001A5 true JP2015516001A5 (enExample) 2016-06-23
JP6136032B2 JP6136032B2 (ja) 2017-05-31

Family

ID=48325708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015510758A Active JP6136032B2 (ja) 2012-05-07 2013-05-06 新規な2,3−ジヒドロ−フロ[2,3−c]ピリジン、Gタンパク質共役受容体GPR119のモジュレーターとしてのそれらの使用、及びそれらを含む医薬組成物

Country Status (4)

Country Link
US (1) US8809361B2 (enExample)
EP (1) EP2847196B1 (enExample)
JP (1) JP6136032B2 (enExample)
WO (1) WO2013167514A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
WO2021236654A1 (en) * 2020-05-18 2021-11-25 The Johns Hopkins University Anti-cancer spirocyclic-guanidine compounds and uses thereof
EP4153589A4 (en) 2020-05-19 2024-06-12 Kallyope, Inc. AMPK ACTIVATORS
WO2021263039A1 (en) 2020-06-26 2021-12-30 Kallyope, Inc. Ampk activators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140161A1 (en) * 2010-05-06 2011-11-10 Bristol-Myers Squibb Company Benzofuranyl analogues as gpr119 modulators
WO2012077655A1 (ja) * 2010-12-07 2012-06-14 塩野義製薬株式会社 Gpr119アゴニスト活性を有するスピロ誘導体
UY33805A (es) * 2010-12-17 2012-07-31 Boehringer Ingelheim Int ?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
EA201300846A1 (ru) * 2011-01-21 2013-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Конденсированные дигидрофураны в качестве модуляторов gpr119, предназначенные для лечения диабета, ожирения и родственных нарушений

Similar Documents

Publication Publication Date Title
JP2014502988A5 (enExample)
JP2013545791A5 (enExample)
JP2014511892A5 (enExample)
JP2016530259A5 (enExample)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
JP2015501799A5 (enExample)
JP2017504631A5 (enExample)
PE20180227A1 (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
JP2018524390A5 (enExample)
JP2014526500A5 (enExample)
JP2018537413A5 (ja) 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
JP2014516070A5 (enExample)
RU2013132930A (ru) Производное пиразола
JP2020502092A5 (enExample)
JP2013542261A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2017501237A5 (enExample)
JP2016519165A5 (enExample)
JP2014509600A5 (enExample)
JP2012513416A5 (enExample)
RU2015101115A (ru) Гетероароматическое циклическое производное с алкильной разветвленной цепью
JP2015516427A5 (enExample)
JP2016540811A5 (enExample)
JP2019505529A5 (enExample)
JP2020507566A5 (enExample)